Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats

World Journal of Gastroenterology

Volumn 12, Issue 42, 2006, Pages 6828-6834

  Aller, Maria Angeles ^a   Angulo, Alejandro ^a   Sńchez Patán, Fernando ^a   Calderón, Ana ^a   Arias, Jaime ^a   Vara, Elena ^a   García, Cruz ^a   Nava, Maria Paz ^a   Vergara, Patri ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cholesterol; Diacylglycerides; Free fatty acids; Phospholipids; Portal hypertension; Triglycerides

Indexed keywords

DIACYLGLYCEROL; FATTY ACID; GLUCOSE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID SYNTHESIS; LIPID METABOLISM; LIPID STORAGE; LIVER METABOLISM; MALE; METABOLIC DISORDER; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PHOSPHOLIPID SYNTHESIS; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PROTEIN DETERMINATION; RAT; SPECTROPHOTOMETRY; THIN LAYER CHROMATOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; VEIN LIGATION;

EID: 33751376909     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i42.6828     Document Type: Article

References (54)

1. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 1981; 240: G371-G375
2. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992; 21:1-14
3. MacMathuna P, Vlavianos P, Westaby D, Williams R. Pathophysiology of portal hypertension. Dig Dis 1992; 10 Suppl 1: 3-15
4. Lin HC, Yang MC, Hou MC, Li SM, Huang YT, Yu PC, Tsai YT, Lee SD. Effects of long-term administration of octreotide in portal vein-stenosed rats. Hepatology 1996; 23: 537-543
5. Aller Reyero MA, Dieguez Fernandez B, Nava Hidalgo MP, Cuesta Alvaro P, Sanchez Garcia M, Duran Gimenez-Rico M, Llamas Matias MA, Arias Perez J. Development of pre-hepatic portal hypertension of the rat. An Med Interna 2002; 19: 341-351
6. Van Thiel DH, Gavaler JS, Cobb CF, McClain CJ. An evaluation of the respective roles of portosysternic shunting and portal hypertension in rats upon the production of gonadal dysfunction in cirrhosis. Gastroenterology 1983; 85: 154-159
7. Alonso MJ, Aller MA, Corcuera MT, Nava MP, Gómez F, Angulo, A, Arias J. Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension. Hepatogastroenterology 2005; 52: 541-546
8. Monterde G, Rodriguez-Fabian G, Vara E, Lopez L, Arias J, Aller MA, Arias J. Increased plasma levels of corticosterone and prolactin and decreased T3 and T4 levels in short-term prehepatic portal hypertension in rats. Dig Dis Sci 2000; 45: 1865-1871
9. Dieguez B, Aller MA, Nava MP, Palma MD, Arias JL, López L, Arias J. Chronic portal hypertension in the rat by triple-portal stenosing ligation. J Invest Surg 2002; 15: 329-336
10. Castaneda B, Debernardi-Venon W, Bandi JC, Andreu V, Perez-del-Pulgar S, Moitinho, E, Pizcueta P, Bosch J. The role of portal pressure in the severity of bleeding in portal hyper-tensive rats. Hepatology 2000; 31: 581-586
11. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology 1986; 90: 1232-1240
12. Tamarit-Rodriguez J, Vara, E, Tamarit J. Starvation-induced changes of palmitate metabolism and insulin secretion in isolated rat islets stimulated by glucose. Biochem J 1984; 221: 317-324
13. Richmond W. Proceedings: The development of an enzymic technique for the assay of cholesterol in biological fluids. Clin Sci Mol Med 1974; 46: 6P-7P
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 244-254
15. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34: 255-262
16. Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 2002; 6: 399-420, vii
17. Solga SF, Diehl AM. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol 2003; 38: 681-687
18. Cortez-Pinto H, Camilo ME. Non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract Res Clin Gastroenterol 2004; 18: 1089-1104
19. Jansen PL. Non-alcoholic steatohepatitis. Eur J Gastroenterol Hepatol 2004; 16: 1079-1085
20. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001; 21: 89-104
21. Kiel JW, Pitts V, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am J Physiol 1985; 248: G192-G195
22. Bomzon A, Blendis LM. Vascular reactivity in experimental portal hypertension. Am J Physiol 1987; 252: G158-G162
23. Sikuler E, Groszmann RJ. Hemodynan-dc studies in long- and short-term portal hypertensive rats: the relation to systemic glucagon levels. Hepatology 1986; 6: 414-418
24. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 2004; 30: 121-138
25. Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol 2004; 16: 1095-1105
26. Tamura S, Shimornura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1139-1142
27. Choudhury J, Sanyal AJ. Insulin resistance in NASH. Front Biosci 2005; 10: 1520-1533
28. Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis 2004; 8: 639-671, xi
29. Diehl AM. Lessons from animal models of NASH. Hepatol Res 2005; 33: 138-144
30. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946
31. Vara E, Arias-Diaz J, TorTes-Melero J, Garcia C, Rodriguez JM, Balibrea JL. Effect of different sepsis-related cytokines on hpid synthesis by isolated hepatocytes. Hepatology 1994; 20: 924-931
32. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343: 1467-1476
33. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 1995; 108: 761-767
34. López-Talavera JC, Cadelina. G, Olchowski J, Merrill W, Groszmann RJ. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 1996; 23: 1616-1621
35. Wiest R, Groszmann RJ. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 1999; 19: 411-426
36. Palma MD, Aller MA, Vara E, Nava MP, García C, Arias-Díaz J, Balibrea JL, Arias J. Portal hypertension produces an evolutive' hepato-intestinal pro- and anti-inflarrunatory response in the rat. Cytokine 2005; 31: 213-226
37. Aller MA, Vara E, Garcia C, Palma MD, Arias JL, Nava MP, Arias J. Proinflammatory liver and antiinflammatory intestinal mediators involved in portal hypertensive rats. Mediators Inflamm 2005; 2005: 101-111
38. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000; 174: 160-171
39. Rao MS, Reddy JK. Peroxisomal beta-oxidation and steatohepatitis. Semin Liver Dis 2001; 21: 43-55
40. Kawakami M, Pekala PH, Lane MD, Cerand A. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA 1982; 79: 912-916
41. Tijburg LB, Geelen MJ, van Golde LM. Regulation of the biosynthesis of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine in the liver. Biochim Biophys Acta 1989; 1004: 1-19
42. Uzun H, Simsek G, Aydin S, Unal E, Karter Y, Yelmen NK, Vehid S, Curgunlu A, Kaya S. Potential effects of L-NAME on alcohol-induced oxidative stress. World J Gastroenterol 2005; 11: 600-604
43. de Oliveira CP, Simplicio FI, de Lima VM, Yuahasi K, Lopasso FP, Alves VA, Abdalla DS, Carrilho FJ, Laurindo FR, de Oliveira MG. Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. World J Gastroenterol 2006; 12: 1905-1911
44. Boczkowski J, Lisdero CL, Lanone S, Carreras MC, Aubier M, Poderoso JJ. Peroxynitrite-mediated mitochondrial dysfunction. Biol Signals Recept 2001; 10: 66-80
45. Cortez-Pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 2006; 44:197-208
46. Prieto I, Jiménez F, Aller MA, Nava MP, Vara E, García C, Arias J. Tumor necrosis factor-alpha, interleukin-lbeta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats. World J Surg 2005; 29: 903-908
47. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 430-434
48. Pelech SL, Vance DE. Regulation of phosphatidylcholine biosynthesis. Biochim Biophys Acta 1984; 779: 217-251
49. Bradbury MW. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G194-G198
50. Esteve E, Ricart W, Fernández-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005; 24: 16-31
51. Diez-Arias JA, Aller MA, Palma MD, Arias JL, Muniz E, Sanchez M, Arias J. Increased duodenal mucosa infiltration by mast cells in rats with portal hypertension. Dig Surg 2001; 18: 34-40
52. Prieto I, Aller MA, Santamaria. L, Nava MP, Madero R, Perez-Robledo JP, Arias J. Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat. J Gastroenterol Hepatol 2005; 20: 1025-1031
53. Sasaguri Y, Tanimoto A. Role of macrophage-derived histamine in atherosclerosis-chronic participation in the inflammatory response - J Atheroscler Thromb 2004; 11: 122-130
54. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004; 21: 210-221